$ACT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Allergan Finance LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Allergan Finance LLC. Get notifications about new insider transactions in Allergan Finance LLC for free.
Page: < prev 1 2 3 4 5 6 7 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2010 | ACT | Actavis, Inc. | FEDIDA MICHAEL J | Director | Grant | A | 0.00 | 5,000 | 0 | 21,668 | 16.7 K to 21.7 K (+30.00 %) |
May 11 2010 | ACT | Actavis, Inc. | BODINE CHRIS W | Director | Grant | A | 0.00 | 5,000 | 0 | 9,288 | 4.3 K to 9.3 K (+116.60 %) |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Option Exercise | M | 35.11 | 4,250 | 149,218 | 0 | |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Option Exercise | M | 27.49 | 6,815 | 187,344 | 0 | |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Option Exercise | M | 27.49 | 18,185 | 499,906 | 0 | |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Sell | S | 40.64 | 91 | 3,698 | 18,861 | 19 K to 18.9 K (-0.48 %) |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Sell | S | 40.60 | 8,133 | 330,200 | 18,952 | 27.1 K to 19 K (-30.03 %) |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Sell | S | 40.62 | 1,300 | 52,806 | 27,085 | 28.4 K to 27.1 K (-4.58 %) |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Sell | S | 40.61 | 826 | 33,544 | 28,385 | 29.2 K to 28.4 K (-2.83 %) |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Sell | S | 40.63 | 4,400 | 178,772 | 29,211 | 33.6 K to 29.2 K (-13.09 %) |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Sell | S | 40.58 | 9,800 | 397,684 | 33,611 | 43.4 K to 33.6 K (-22.57 %) |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Sell | S | 40.59 | 4,700 | 190,773 | 43,411 | 48.1 K to 43.4 K (-9.77 %) |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Buy | M | 35.11 | 4,250 | 149,218 | 48,111 | 43.9 K to 48.1 K (+9.69 %) |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Buy | M | 27.49 | 6,815 | 187,344 | 43,861 | 37 K to 43.9 K (+18.40 %) |
Mar 17 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Buy | M | 27.49 | 18,185 | 499,906 | 37,046 | 18.9 K to 37 K (+96.42 %) |
Mar 17 2010 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Option Exercise | M | 29.03 | 5,000 | 145,150 | 0 | |
Mar 17 2010 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 41.12 | 5,000 | 205,600 | 5,000 | 10 K to 5 K (-50.00 %) |
Mar 17 2010 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Buy | M | 29.03 | 5,000 | 145,150 | 10,000 | 5 K to 10 K (+100.00 %) |
Mar 16 2010 | ACT | Actavis, Inc. | PAONESSA ALBERT III | EVP & COO of Anda, ... | Payment of Exercise | F | 41.37 | 1,587 | 65,654 | 40,711 | 42.3 K to 40.7 K (-3.75 %) |
Mar 16 2010 | ACT | Actavis, Inc. | Russillo Thomas R | EVP, Global Generic ... | Payment of Exercise | F | 41.37 | 2,751 | 113,809 | 63,370 | 66.1 K to 63.4 K (-4.16 %) |
Mar 16 2010 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Payment of Exercise | F | 41.37 | 1,541 | 63,751 | 18,861 | 20.4 K to 18.9 K (-7.55 %) |
Mar 16 2010 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Payment of Exercise | F | 41.37 | 827 | 34,213 | 19,089 | 19.9 K to 19.1 K (-4.15 %) |
Mar 16 2010 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Payment of Exercise | F | 41.37 | 843 | 34,875 | 31,788 | 32.6 K to 31.8 K (-2.58 %) |
Mar 16 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Payment of Exercise | F | 41.37 | 1,192 | 49,313 | 33,411 | 34.6 K to 33.4 K (-3.44 %) |
Mar 16 2010 | ACT | Actavis, Inc. | HEIMERS EDWARD F JR | EVP and President, ... | Payment of Exercise | F | 41.37 | 1,784 | 73,804 | 21,826 | 23.6 K to 21.8 K (-7.56 %) |
Mar 16 2010 | ACT | Actavis, Inc. | GIORDANO THOMAS R | Sr VP and CIO | Payment of Exercise | F | 41.37 | 859 | 35,537 | 31,052 | 31.9 K to 31.1 K (-2.69 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 25.64 | 1,999 | 51,254 | 0 | |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 25.64 | 1,001 | 25,666 | 1,000 | |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 35.11 | 3,684 | 129,345 | 0 | |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 35.11 | 316 | 11,095 | 0 | |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 26.14 | 8,757 | 228,908 | 3,400 | |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 26.14 | 4,843 | 126,596 | 0 | |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 38.92 | 6,400 | 249,088 | 0 | |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 38.92 | 1,600 | 62,272 | 0 | |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Payment of Exercise | F | 41.37 | 1,265 | 52,333 | 29,004 | 30.3 K to 29 K (-4.18 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Sell | S | 40.85 | 24,650 | 1,006,953 | 30,269 | 54.9 K to 30.3 K (-44.88 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Sell | S | 40.87 | 200 | 8,173 | 54,919 | 55.1 K to 54.9 K (-0.36 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Sell | S | 40.88 | 200 | 8,175 | 55,119 | 55.3 K to 55.1 K (-0.36 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Sell | S | 40.87 | 850 | 34,740 | 55,319 | 56.2 K to 55.3 K (-1.51 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Sell | S | 40.86 | 1,500 | 61,290 | 56,169 | 57.7 K to 56.2 K (-2.60 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Sell | S | 40.88 | 1,200 | 49,056 | 57,669 | 58.9 K to 57.7 K (-2.04 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 25.64 | 1,999 | 51,254 | 58,869 | 56.9 K to 58.9 K (+3.52 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 25.64 | 1,001 | 25,666 | 56,870 | 55.9 K to 56.9 K (+1.79 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 35.11 | 3,684 | 129,345 | 55,869 | 52.2 K to 55.9 K (+7.06 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 35.11 | 316 | 11,095 | 52,185 | 51.9 K to 52.2 K (+0.61 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 26.14 | 8,757 | 228,908 | 51,869 | 43.1 K to 51.9 K (+20.31 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 26.14 | 4,843 | 126,596 | 43,112 | 38.3 K to 43.1 K (+12.66 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 38.92 | 6,400 | 249,088 | 38,269 | 31.9 K to 38.3 K (+20.08 %) |
Mar 16 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 38.92 | 1,600 | 62,272 | 31,869 | 30.3 K to 31.9 K (+5.29 %) |
Mar 16 2010 | ACT | Actavis, Inc. | BUCHEN DAVID A | Sr. VP, General Cou ... | Payment of Exercise | F | 41.37 | 2,751 | 113,809 | 52,371 | 55.1 K to 52.4 K (-4.99 %) |
Mar 16 2010 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Payment of Exercise | F | 41.37 | 1,654 | 68,426 | 38,913 | 40.6 K to 38.9 K (-4.08 %) |
Mar 16 2010 | ACT | Actavis, Inc. | BISARO PAUL | President & CEO | Payment of Exercise | F | 41.37 | 5,978 | 247,310 | 221,295 | 227.3 K to 221.3 K (-2.63 %) |
Mar 16 2010 | ACT | Actavis, Inc. | AMATO LYNNE | VP, Brand Sales & O ... | Payment of Exercise | F | 41.37 | 762 | 31,524 | 18,443 | 19.2 K to 18.4 K (-3.97 %) |
Feb 26 2010 | ACT | Actavis, Inc. | Wilkinson George Fred | Exec.VP-Global Bran ... | Grant | A | 0.00 | 12,008 | 0 | 26,568 | 14.6 K to 26.6 K (+82.47 %) |
Feb 26 2010 | ACT | Actavis, Inc. | Stewart Robert A | Sr VP,Global Operat ... | Grant | A | 0.00 | 10,000 | 0 | 32,000 | 22 K to 32 K (+45.45 %) |
Feb 26 2010 | ACT | Actavis, Inc. | Power Anna | Sr VP,Global Generi ... | Grant | A | 0.00 | 6,800 | 0 | 6,800 | 0 to 6.8 K |
Feb 26 2010 | ACT | Actavis, Inc. | PAONESSA ALBERT III | EVP & COO of Anda, ... | Grant | A | 0.00 | 13,218 | 0 | 42,298 | 29.1 K to 42.3 K (+45.45 %) |
Feb 26 2010 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Grant | A | 0.00 | 5,628 | 0 | 19,916 | 14.3 K to 19.9 K (+39.39 %) |
Feb 26 2010 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Grant | A | 0.00 | 11,456 | 0 | 32,631 | 21.2 K to 32.6 K (+54.10 %) |
Feb 26 2010 | ACT | Actavis, Inc. | Mayr Charles M | Sr VP,Corporate Aff ... | Grant | A | 0.00 | 2,673 | 0 | 6,573 | 3.9 K to 6.6 K (+68.54 %) |
Feb 26 2010 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Grant | A | 0.00 | 9,692 | 0 | 34,603 | 24.9 K to 34.6 K (+38.91 %) |
Feb 26 2010 | ACT | Actavis, Inc. | GIORDANO THOMAS R | Sr VP and CIO | Grant | A | 0.00 | 8,812 | 0 | 31,911 | 23.1 K to 31.9 K (+38.15 %) |
Feb 26 2010 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Grant | A | 0.00 | 8,812 | 0 | 30,269 | 21.5 K to 30.3 K (+41.07 %) |
Feb 26 2010 | ACT | Actavis, Inc. | Carmichael Clare | SR VP, Human Resour ... | Grant | A | 0.00 | 9,414 | 0 | 19,433 | 10 K to 19.4 K (+93.96 %) |
Feb 26 2010 | ACT | Actavis, Inc. | BUCHEN DAVID A | Sr. VP, General Cou ... | Grant | A | 0.00 | 16,523 | 0 | 55,122 | 38.6 K to 55.1 K (+42.81 %) |
Feb 26 2010 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Grant | A | 0.00 | 10,015 | 0 | 40,567 | 30.6 K to 40.6 K (+32.78 %) |
Feb 26 2010 | ACT | Actavis, Inc. | BISARO PAUL | President & CEO | Grant | A | 0.00 | 81,181 | 0 | 227,273 | 146.1 K to 227.3 K (+55.57 %) |
Feb 26 2010 | ACT | Actavis, Inc. | AMATO LYNNE | VP, Brand Sales & O ... | Grant | A | 0.00 | 5,728 | 0 | 19,205 | 13.5 K to 19.2 K (+42.50 %) |
Feb 23 2010 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Payment of Exercise | F | 39.11 | 1,204 | 47,088 | 21,175 | 22.4 K to 21.2 K (-5.38 %) |
Jan 04 2010 | ACT | Actavis, Inc. | Russillo Thomas R | EVP, Global Generic ... | Payment of Exercise | F | 39.61 | 3,668 | 145,289 | 66,121 | 69.8 K to 66.1 K (-5.26 %) |
Dec 17 2009 | ACT | Actavis, Inc. | GIORDANO THOMAS R | Sr VP and CIO | Option Exercise | M | 25.62 | 10,000 | 256,200 | 5,612 | |
Dec 17 2009 | ACT | Actavis, Inc. | GIORDANO THOMAS R | Sr VP and CIO | Sell | S | 38.47 | 10,000 | 384,700 | 23,099 | 33.1 K to 23.1 K (-30.21 %) |
Dec 17 2009 | ACT | Actavis, Inc. | GIORDANO THOMAS R | Sr VP and CIO | Buy | M | 25.62 | 10,000 | 256,200 | 33,099 | 23.1 K to 33.1 K (+43.29 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Option Exercise | M | 28.74 | 5,653 | 162,467 | 0 | |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Option Exercise | M | 28.15 | 20,000 | 563,000 | 0 | |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Sell | S | 38.30 | 10,806 | 413,870 | 14,288 | 25.1 K to 14.3 K (-43.06 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Sell | S | 38.35 | 1,068 | 40,958 | 25,094 | 26.2 K to 25.1 K (-4.08 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Sell | S | 38.37 | 4,000 | 153,480 | 26,162 | 30.2 K to 26.2 K (-13.26 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Sell | S | 38.40 | 2,500 | 96,000 | 30,162 | 32.7 K to 30.2 K (-7.65 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Sell | S | 38.24 | 1,500 | 57,360 | 32,662 | 34.2 K to 32.7 K (-4.39 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Sell | S | 38.28 | 3,000 | 114,840 | 34,162 | 37.2 K to 34.2 K (-8.07 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Sell | S | 38.26 | 353 | 13,506 | 37,162 | 37.5 K to 37.2 K (-0.94 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Sell | S | 38.25 | 300 | 11,475 | 37,515 | 37.8 K to 37.5 K (-0.79 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Sell | S | 38.36 | 1,126 | 43,193 | 37,815 | 38.9 K to 37.8 K (-2.89 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Sell | S | 38.21 | 600 | 22,926 | 38,941 | 39.5 K to 38.9 K (-1.52 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Sell | S | 38.20 | 400 | 15,280 | 39,541 | 39.9 K to 39.5 K (-1.00 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Buy | M | 28.74 | 5,653 | 162,467 | 39,941 | 34.3 K to 39.9 K (+16.49 %) |
Dec 11 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Buy | M | 28.15 | 20,000 | 563,000 | 34,288 | 14.3 K to 34.3 K (+139.98 %) |
Dec 11 2009 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 26.40 | 4,162 | 109,877 | 0 | |
Dec 11 2009 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 26.40 | 3,838 | 101,323 | 0 | |
Dec 11 2009 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 27.88 | 10,997 | 306,596 | 0 | |
Dec 11 2009 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Option Exercise | M | 27.88 | 3 | 84 | 0 | |
Dec 11 2009 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Sell | S | 38.25 | 19,000 | 726,750 | 21,457 | 40.5 K to 21.5 K (-46.96 %) |
Dec 11 2009 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 26.40 | 4,162 | 109,877 | 40,457 | 36.3 K to 40.5 K (+11.47 %) |
Dec 11 2009 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 26.40 | 3,838 | 101,323 | 36,295 | 32.5 K to 36.3 K (+11.82 %) |
Dec 11 2009 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 27.88 | 10,997 | 306,596 | 32,457 | 21.5 K to 32.5 K (+51.24 %) |
Dec 11 2009 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Buy | M | 27.88 | 3 | 84 | 21,460 | 21.5 K to 21.5 K (+0.01 %) |
Dec 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 38.36 | 25 | 959 | 5,000 | 5 K to 5 K (-0.50 %) |
Dec 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 38.22 | 1,500 | 57,330 | 5,025 | 6.5 K to 5 K (-22.99 %) |
Dec 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 38.30 | 919 | 35,198 | 6,525 | 7.4 K to 6.5 K (-12.35 %) |
Dec 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 38.15 | 1,000 | 38,150 | 7,444 | 8.4 K to 7.4 K (-11.84 %) |
Dec 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 38.21 | 1,000 | 38,210 | 8,444 | 9.4 K to 8.4 K (-10.59 %) |
Dec 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 38.11 | 500 | 19,055 | 9,444 | 9.9 K to 9.4 K (-5.03 %) |
Dec 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 38.26 | 1,500 | 57,390 | 9,944 | 11.4 K to 9.9 K (-13.11 %) |
Dec 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 38.35 | 56 | 2,148 | 11,444 | 11.5 K to 11.4 K (-0.49 %) |
Dec 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 38.25 | 1,500 | 57,375 | 11,500 | 13 K to 11.5 K (-11.54 %) |
Dec 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 38.20 | 1,500 | 57,300 | 13,000 | 14.5 K to 13 K (-10.34 %) |
Dec 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Sell | S | 38.18 | 501 | 19,128 | 14,500 | 15 K to 14.5 K (-3.34 %) |
Nov 17 2009 | ACT | Actavis, Inc. | Stewart Robert A | Sr VP,Global Operat ... | Grant | A | 0.00 | 22,000 | 0 | 22,000 | 0 to 22 K |
Oct 30 2009 | ACT | Actavis, Inc. | JOYCE R TODD | Sr Vice Pres. & CFO | Grant | A | 0.00 | 6,800 | 0 | 24,911 | 18.1 K to 24.9 K (+37.55 %) |
Sep 22 2009 | ACT | Actavis, Inc. | Mayr Charles M | Sr VP,Corp.Com & In ... | Grant | A | 0.00 | 3,900 | 0 | 3,900 | 0 to 3.9 K |
Sep 22 2009 | ACT | Actavis, Inc. | Wilkinson George Fred | Exec.VP-Global Bran ... | Grant | A | 0.00 | 12,500 | 0 | 14,560 | 2.1 K to 14.6 K (+606.80 %) |
Sep 08 2009 | ACT | Actavis, Inc. | BISARO PAUL | President & CEO | Payment of Exercise | F | 34.81 | 6,911 | 240,572 | 146,092 | 153 K to 146.1 K (-4.52 %) |
Aug 13 2009 | ACT | Actavis, Inc. | Russillo Thomas R | EVP & Pres US Gener ... | Grant | A | 0.00 | 7,500 | 0 | 69,789 | 62.3 K to 69.8 K (+12.04 %) |
Aug 13 2009 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Payment of Exercise | F | 34.63 | 233 | 8,069 | 20,402 | 20.6 K to 20.4 K (-1.13 %) |
Aug 13 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Payment of Exercise | F | 34.63 | 162 | 5,610 | 14,288 | 14.5 K to 14.3 K (-1.12 %) |
Aug 13 2009 | ACT | Actavis, Inc. | JOYCE R TODD | VP, Corp. Controlle ... | Payment of Exercise | F | 34.63 | 178 | 6,164 | 18,111 | 18.3 K to 18.1 K (-0.97 %) |
Aug 13 2009 | ACT | Actavis, Inc. | HEIMERS EDWARD F JR | EVP and President, ... | Payment of Exercise | F | 34.63 | 270 | 9,350 | 23,610 | 23.9 K to 23.6 K (-1.13 %) |
Aug 13 2009 | ACT | Actavis, Inc. | Eisenhaur Patricia L. | VP, Investor Relati ... | Payment of Exercise | F | 34.63 | 67 | 2,320 | 7,865 | 7.9 K to 7.9 K (-0.84 %) |
Aug 13 2009 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Payment of Exercise | F | 34.63 | 215 | 7,445 | 21,457 | 21.7 K to 21.5 K (-0.99 %) |
Aug 13 2009 | ACT | Actavis, Inc. | BUCHEN DAVID A | Sr. VP, General Cou ... | Payment of Exercise | F | 34.63 | 298 | 10,320 | 38,599 | 38.9 K to 38.6 K (-0.77 %) |
Aug 13 2009 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Payment of Exercise | F | 34.63 | 270 | 9,350 | 30,552 | 30.8 K to 30.6 K (-0.88 %) |
Aug 13 2009 | ACT | Actavis, Inc. | AMATO LYNNE | VP, Brand Sales & O ... | Payment of Exercise | F | 34.63 | 189 | 6,545 | 13,477 | 13.7 K to 13.5 K (-1.38 %) |
Jul 20 2009 | ACT | Actavis, Inc. | Brunner Patrick G. | SVP,Manufacturing O ... | Payment of Exercise | F | 33.24 | 621 | 20,642 | 21,033 | 21.7 K to 21 K (-2.87 %) |
Jun 30 2009 | ACT | Actavis, Inc. | BODINE CHRIS W | Director | Grant | A | 0.00 | 4,288 | 0 | 4,288 | 0 to 4.3 K |
May 18 2009 | ACT | Actavis, Inc. | Eisenhaur Patty | VP, Investor Relati ... | Grant | A | 0.00 | 2,700 | 0 | 7,932 | 5.2 K to 7.9 K (+51.61 %) |
May 11 2009 | ACT | Actavis, Inc. | WEISS FRED G | Director | Grant | A | 0.00 | 5,000 | 0 | 14,334 | 9.3 K to 14.3 K (+53.57 %) |
May 11 2009 | ACT | Actavis, Inc. | TURNER ANDREW L | Director | Grant | A | 0.00 | 5,000 | 0 | 15,001 | 10 K to 15 K (+50.00 %) |
May 11 2009 | ACT | Actavis, Inc. | TAYLOR RONALD R | Director | Grant | A | 0.00 | 5,000 | 0 | 15,001 | 10 K to 15 K (+50.00 %) |
May 11 2009 | ACT | Actavis, Inc. | MICHELSON JACK | Director | Grant | A | 0.00 | 5,000 | 0 | 15,001 | 10 K to 15 K (+50.00 %) |
May 11 2009 | ACT | Actavis, Inc. | KLEMA CATHY | Director | Grant | A | 0.00 | 5,000 | 0 | 16,668 | 11.7 K to 16.7 K (+42.85 %) |
May 11 2009 | ACT | Actavis, Inc. | HUMMEL ALBERT F | Director | Grant | A | 0.00 | 5,000 | 0 | 164,514 | 159.5 K to 164.5 K (+3.13 %) |
May 11 2009 | ACT | Actavis, Inc. | FELDMAN MICHEL J | Director | Grant | A | 0.00 | 5,000 | 0 | 13,334 | 8.3 K to 13.3 K (+60.00 %) |
May 11 2009 | ACT | Actavis, Inc. | FEDIDA MICHAEL J | Director | Grant | A | 0.00 | 5,000 | 0 | 16,668 | 11.7 K to 16.7 K (+42.85 %) |
Mar 13 2009 | ACT | Actavis, Inc. | Russillo Thomas R | EVP & Pres US Gener ... | Payment of Exercise | F | 27.34 | 2,681 | 73,299 | 62,289 | 65 K to 62.3 K (-4.13 %) |
Mar 13 2009 | ACT | Actavis, Inc. | PAONESSA ALBERT III | EVP & COO of Anda, ... | Payment of Exercise | F | 27.34 | 899 | 24,579 | 29,080 | 30 K to 29.1 K (-3.00 %) |
Mar 13 2009 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Payment of Exercise | F | 27.34 | 811 | 22,173 | 20,635 | 21.4 K to 20.6 K (-3.78 %) |
Mar 13 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Payment of Exercise | F | 27.34 | 405 | 11,073 | 14,450 | 14.9 K to 14.5 K (-2.73 %) |
Mar 13 2009 | ACT | Actavis, Inc. | JOYCE R TODD | VP, Corp. Controlle ... | Payment of Exercise | F | 27.34 | 536 | 14,654 | 18,289 | 18.8 K to 18.3 K (-2.85 %) |
Mar 13 2009 | ACT | Actavis, Inc. | GIORDANO THOMAS R | Sr VP and CIO | Payment of Exercise | F | 27.34 | 396 | 10,827 | 23,099 | 23.5 K to 23.1 K (-1.69 %) |
Mar 13 2009 | ACT | Actavis, Inc. | HEIMERS EDWARD F JR | EVP and President, ... | Payment of Exercise | F | 27.34 | 892 | 24,387 | 23,880 | 24.8 K to 23.9 K (-3.60 %) |
Mar 13 2009 | ACT | Actavis, Inc. | BUCHEN DAVID A | Sr. VP, General Cou ... | Payment of Exercise | F | 27.34 | 1,340 | 36,636 | 38,897 | 40.2 K to 38.9 K (-3.33 %) |
Mar 13 2009 | ACT | Actavis, Inc. | EBERT CHARLES D | Sr. VP, Research & ... | Payment of Exercise | F | 27.34 | 616 | 16,841 | 21,672 | 22.3 K to 21.7 K (-2.76 %) |
Mar 13 2009 | ACT | Actavis, Inc. | BOYER ANDREW S | SVP,Sales&Mktg,US G ... | Payment of Exercise | F | 27.34 | 843 | 23,048 | 30,822 | 31.7 K to 30.8 K (-2.66 %) |
Mar 13 2009 | ACT | Actavis, Inc. | AMATO LYNNE | VP, Brand Sales & O ... | Payment of Exercise | F | 27.34 | 340 | 9,296 | 13,666 | 14 K to 13.7 K (-2.43 %) |
Mar 06 2009 | ACT | Actavis, Inc. | Russillo Thomas R | EVP & Pres US Gener ... | Grant | A | 0.00 | 7,470 | 0 | 64,970 | 57.5 K to 65 K (+12.99 %) |
Mar 06 2009 | ACT | Actavis, Inc. | PAONESSA ALBERT III | EVP & COO of Anda, ... | Grant | A | 0.00 | 11,179 | 0 | 29,979 | 18.8 K to 30 K (+59.46 %) |
Mar 06 2009 | ACT | Actavis, Inc. | MUNRO GORDON | Sr. VP, Quality Ass ... | Grant | A | 0.00 | 4,482 | 0 | 21,446 | 17 K to 21.4 K (+26.42 %) |
Mar 06 2009 | ACT | Actavis, Inc. | MIRANDA DIANE F | VP,Generic Marketin ... | Grant | A | 0.00 | 5,190 | 0 | 14,855 | 9.7 K to 14.9 K (+53.70 %) |
Mar 06 2009 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Grant | A | 0.00 | 10,379 | 0 | 22,379 | 12 K to 22.4 K (+86.49 %) |